Biolife Solutions (BLFS) Equity Average (2011 - 2026)

Biolife Solutions (BLFS) has 16 years of Equity Average data on file, last reported at $372.1 million in Q1 2026.

• Equity Average for Q1 2026 came in at $372.1 million, up 6.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.1 million (up 6.07% YoY), and the FY2025 annual result was $360.4 million, up 4.98% from the prior year.
• Equity Average grew to $372.1 million in Q1 2026 per BLFS's latest filing, from $362.8 million in the prior quarter.
• Over five years, Equity Average peaked at $477.1 million in Q1 2022 and troughed at $323.5 million in Q3 2024.
• A 5-year average of $365.6 million and a median of $350.8 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2023: Equity Average surged 130.91% in 2022, then slipped 24.3% in 2023.
• A 5-year view of Equity Average shows it stood at $384.7 million in 2022, then retreated by 12.95% to $334.8 million in 2023, then rose by 0.7% to $337.2 million in 2024, then advanced by 7.6% to $362.8 million in 2025, then grew by 2.55% to $372.1 million in 2026.
• Business Quant data shows BLFS's Equity Average at $372.1 million in Q1 2026, $362.8 million in Q4 2025, and $350.4 million in Q3 2025.